A fructosamine test measures glycated serum proteins — mostly albumin — and reflects average blood glucose over the prior 2 to 3 weeks. It is not a screening test for diabetes. Clinicians order it when A1C results are unreliable or when they need a faster snapshot of glucose control than A1C can provide.
What Fructosamine Actually Is
“Fructosamine” is a generic term for any glycated protein in serum — that is, a serum protein with glucose chemically attached. Albumin is the most abundant serum protein, so most of what a fructosamine assay measures is glycated albumin. Albumin has a half-life of about 14 to 20 days, which is why fructosamine reflects glucose control over the prior 2 to 3 weeks.
By contrast, hemoglobin (measured in the A1C test) is housed in red blood cells with a 120-day lifespan, so A1C reflects roughly 3 months of average glucose. Faster turnover means a faster signal but also more day-to-day noise.
Normal Range and Interpretation
| Fructosamine (µmol/L) | Interpretation |
|---|---|
| 200 to 285 | Typical non-diabetic range |
| 286 to 320 | Suggests good diabetes control |
| 321 to 370 | Fair control |
| Above 370 | Poor control; clinician follow-up |
Reference ranges vary by laboratory. Always interpret a fructosamine result against the range printed on the report, not against generic figures.
Approximate Translation to Average Glucose and A1C
There is no universally accepted formula, but several published estimates allow rough conversion:
| Fructosamine (µmol/L) | Estimated A1C (%) | Approximate Average Glucose (mg/dL) |
|---|---|---|
| 212 | 5.0 | 97 |
| 250 | 6.0 | 126 |
| 290 | 7.0 | 154 |
| 330 | 8.0 | 183 |
| 370 | 9.0 | 212 |
For a refresher on what those A1C numbers mean clinically, see our overview of A1C levels.
When Fructosamine Is Used Instead of A1C
A1C is the standard for tracking diabetes control, but several conditions distort the result. In those situations, fructosamine becomes useful:
- Hemoglobinopathies: Sickle cell trait or disease, beta-thalassemia, and certain hemoglobin variants interfere with A1C assays.
- Hemolytic anemia: Faster red-cell turnover lowers A1C artificially.
- Recent blood transfusion: Transfused red cells alter the A1C measurement.
- Iron deficiency anemia: Can falsely elevate A1C.
- Late pregnancy: Red-cell turnover changes; some clinicians prefer fructosamine for monitoring gestational diabetes.
- Recent medication change: Useful to assess response to a new diabetes drug after just 2 to 3 weeks rather than waiting 3 months.
How the Test Is Performed
Fructosamine requires a routine venous blood draw. No fasting is required. Most labs (LabCorp, Quest Diagnostics) report results within 24 to 72 hours. The assay uses nitroblue tetrazolium reduction or an enzymatic colorimetric method, depending on the lab.
What Can Skew Fructosamine Results
Several conditions affect serum protein levels and therefore can shift fructosamine independent of average glucose:
- Low albumin (hypoalbuminemia): Liver disease, nephrotic syndrome, and protein-losing enteropathy lower albumin and can falsely lower fructosamine.
- High vitamin C intake: Can interfere with some assay methods.
- Hyperthyroidism: Faster protein turnover can lower fructosamine.
- Hypothyroidism: Slower turnover can raise fructosamine.
Clinicians factor these into interpretation. When in doubt, glycated albumin or continuous glucose monitor data may be substituted.
Fructosamine Is Not a Diabetes Screening Test
The American Diabetes Association recommends fasting glucose, A1C, or oral glucose tolerance for diabetes screening. Fructosamine is a monitoring tool, not a diagnostic one. If you are wondering whether you have prediabetes or diabetes, ask your clinician about screening tests covered in our detection of prediabetes guide.
Cost and Availability
Cash price for a fructosamine test runs roughly 20 to 60 dollars at major US laboratories. It is covered by most insurance when ordered by a clinician for an appropriate indication (a documented A1C-confounding condition or a need for short-interval monitoring).
Talking to Your Clinician
If you have one of the conditions that distorts A1C — sickle cell trait, recent transfusion, late pregnancy — ask whether fructosamine or glycated albumin would give a better picture of your glucose control. If you are recovering from a medication change and want a faster check than waiting 3 months, fructosamine in 4 to 6 weeks may be reasonable.
The Bottom Line
The fructosamine test is a useful but specialized tool. It captures the prior 2 to 3 weeks of average glucose and steps in when A1C cannot be trusted. Always interpret it with the lab’s own reference range, factor in albumin and thyroid status, and do not use it as a substitute for diabetes screening tests.
